Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Year in Review
  • Published:

Epilepsy in 2011

Insights into epilepsy treatments and biomarkers

Research published in 2011 identified important factors related to serious adverse effects of antiepileptic drugs and sudden unexpected death in epilepsy, along with a potential new treatment and a promising marker of epileptogenesis. Further advances in these areas are urgently needed to improve the lives of people with epilepsy.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kwan, P. et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 51, 1069–1077 (2010).

    Article  CAS  PubMed  Google Scholar 

  2. Hesdorffer, D. C. et al. Combined analysis of risk factors for SUDEP. Epilepsia 52, 1150–1159 (2011).

    Article  PubMed  Google Scholar 

  3. Jeon, D. et al. A cell-free extract from human adipose stem cells protects mice against epilepsy. Epilepsia 52, 1617–1626 (2011).

    Article  PubMed  Google Scholar 

  4. Cavalheiro, E. A. et al. Long-term effects of pilocarpine in rats: structural damage of the brain triggers kindling and spontaneous recurrent seizures. Epilepsia 32, 778–782 (1991).

    Article  CAS  PubMed  Google Scholar 

  5. Vezzani, A., French, J., Bartfai, T. & Baram, T. Z. The role of inflammation in epilepsy. Nat. Rev. Neurol. 7, 31–40 (2011).

    Article  CAS  PubMed  Google Scholar 

  6. McCormack, M. et al. HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N. Engl. J. Med. 364, 1134–1143 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Tomson, T. et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol. 10, 609–617 (2011).

    Article  CAS  PubMed  Google Scholar 

  8. Chen, P. et al. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. N. Engl. J. Med. 364, 1126–1133 (2011).

    Article  CAS  PubMed  Google Scholar 

  9. Andrade-Valença, L. P., Dubeau, F., Mari, F., Zelmann, R. & Gotman, J. Interictal scalp fast oscillations as a marker of the seizure onset zone. Neurology 77, 524–531 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

  10. Cendes, F. & Engel, J. Jr. Extending applications for high-frequency oscillations: the ripple effect. Neurology 77, 518–519 (2011).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cendes, F. Insights into epilepsy treatments and biomarkers. Nat Rev Neurol 8, 70–71 (2012). https://doi.org/10.1038/nrneurol.2011.223

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2011.223

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research